| European Rare Blood Disorders Platform (ENROL) (NCT06250595) | Hospital Universitari Vall d'Hebron Research Institute | 2022-07-01 |
| Early Integration of Palliative and Supportive Care in Cellular Therapy (NCT05190653) | Alberta Health Services, Calgary | 2022-04-08 |
| Positive Psychology Intervention In HSCT (NCT05147311) | Brigham and Women's Hospital | 2021-11-17 |
| A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms (NCT04955938) | University of Chicago | 2021-10-29 |
| Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy (NCT04390542) | Case Comprehensive Cancer Center | 2021-06-01 |
| Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation (NCT04737785) | European Society for Blood and Marrow Transplantation | 2021-01-01 |
| Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients (NCT05709522) | Aga Khan University | 2020-11-20 |
| Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study (NCT04372524) | University of British Columbia | 2020-11-15 |
| A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer (NCT04419623) | Telios Pharma, Inc. | 2020-07-09 |
| Better Leukemia Diagnostics Through AI (BELUGA) (NCT04466059) | Munich Leukemia Laboratory | 2020-01-05 |
| Rehabilitation Needs of the Malaysian Haematological Cancer Survivors (NCT04236063) | University of Malaya | 2019-07-15 |
| Resiliency in Older Adults Undergoing Bone Marrow Transplant (NCT04188678) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-09-28 |
| A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients (NCT03654404) | Brigham and Women's Hospital | 2018-09-11 |
| Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy. (NCT05450367) | Assistance Publique - Hôpitaux de Paris | 2017-08-01 |
| The Leukemia and Lymphoma Society (LLS) National Research Registry (NCT04806295) | Blood Cancer United | 2017-07-24 |
| Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL (NCT02361346) | Molecular Templates, Inc. | 2015-02-01 |
| A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies (NCT01957579) | AstraZeneca | 2011-05-25 |
| Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors (NCT00962494) | Stanford University | 2009-07-01 |
| TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD (NCT00185796) | Stanford University | 2004-07-01 |
| Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies (NCT00185640) | Stanford University | 2003-03-01 |
| A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) (NCT00230321) | Peter L Greenberg | 2002-02-01 |
| Allogeneic Transplantation From Related Haploidentical Donors (NCT00185692) | Stanford University | 2000-08-01 |
| Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma (NCT00185614) | Wen-Kai Weng | 2000-08-01 |
| Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors (NCT00186225) | Stanford University | 1989-11-01 |